Submitted by Anonymous (not verified) on 8 April 2026 - 15:48
Human medicines European public assessment report (EPAR): Supemtek, trivalent influenza vaccine (recombinant, prepared in cell culture), Date of authorisation: 30/03/2026, Status: Authorised
Source: